Elucidating the FOXF1 gene regulatory network in human alveologenesis
阐明人类肺泡发生中的 FOXF1 基因调控网络
基本信息
- 批准号:10558865
- 负责人:
- 金额:$ 66.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-15 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalATAC-seqAffectAlveolarAlveolar capillary dysplasia with misalignment of pulmonary veinsBenchmarkingBlood VesselsBlood capillariesCell CommunicationCell NucleusCellsCoculture TechniquesDataData SetDeletion MutationDevelopmentDiseaseDistalEndodermEndothelial CellsEndotheliumEpithelial CellsEpitheliumEtiologyEventFOXF1 geneGene ExpressionGene Expression RegulationGenesGoalsHeterozygoteHomeostasisHumanIn VitroInjuryLeadLigandsLungMapsMediatingMesodermModelingMolecularMusMutationOrganoidsPTEN genePTK2 genePathway interactionsPatientsPatternPerfusionPhasePlayPoint MutationPopulationRNARegulationRoleSamplingSignal PathwaySignal TransductionSiteStructure of parenchyma of lungSystemTGFB2 geneTGFBR2 geneTestingTransforming Growth Factor Beta 2Transforming Growth Factor betaVariantVascularizationcell typedevelopmental diseaseendothelial stem cellforkhead proteingene networkgene regulatory networkgenetic signaturegenomic locusimprovedinduced pluripotent stem cellinjuredinsightlung developmentmutantmutant mouse modelnew therapeutic targetnovelpostnatalpostnatal humanprenatalpreventprogenitorpublic health relevancereceptorreceptor bindingrepairedsingle nucleus RNA-sequencingtranscription factortranscriptomics
项目摘要
PROJECT SUMMARY
The overarching goal of the proposed study is to uncover the molecular mechanism underlying FOXF1-mediated
temporal and spatial coordination of multiple alveolar endothelial and epithelial cell subtypes. FOXF1 (Forkhead
Box F1) is a transcription factor that plays a pivotal role in lung vascular development, homeostasis, and repair
after injury. Heterozygous deletions or point mutations in FOXF1 are associated with alveolar-capillary dysplasia
with misalignment of pulmonary veins (ACD/MPV), a lethal lung developmental disorder with no cure. Although
the Foxf1 mutant mouse model has been created to study ACD, there are certain variations in gene signatures
of EC subtypes and developmental timing of the alveolarization in mouse vs. human, limiting its application in
understanding ACD human etiology. Thus, it remains unclear how FOXF1 regulates downstream gene networks
to drive the formation of alveolar endothelial cell (EC) subtypes and maintain normal EC-epithelial cell (EpiC)
crosstalk during alveologenesis in human. Our preliminary studies showed that FOXF1 mutations lead to distinct
cell population and transcriptomic changes in two newly identified alveolar EC subtypes- aerocyte (aCap) and
general capillary (gCap), based on single nuclei RNA-sequencing in control and ACD human lung tissues. More
interestingly, although FOXF1 does not express in epithelial lineage, alveolar type 1 (AT1) EpiC population was
significantly reduced, and damage-associated transient epithelial progenitors (DATPs) were increased in FOXF1
mutant human lung. Ligand-receptor binding analysis revealed disrupted TGFβ signaling in aCap (TGFB2)-AT1
(TGFBR2/3) interaction. Therefore, we hypothesized that FOXF1 regulates distinct pathways in aCap and gCap
cells, and FOXF1-dependent TGFβ2 secretion by aCap is critical in maintaining AT1 identity and function. We
propose to test this hypothesis with the following specific aims: Aim 1: Determine the role of FOXF1 in regulating
differentiation and function of alveolar EC subtypes. Aim 2: Determine the impact of aCap cells on maintaining
AT1 identity and function. Aim 3: Uncover FOXF1 mediated early lung development using iPSC derived organoid
systems. For Aim 3, we established 3D vascularized alveolar organoid models from control and ACD induced
pluripotent stem cells (iPSCs), to study FOXF1 gene regulation and dynamic EC-EpiC interactions across
multiple lung developmental stages. Completion of the three aims will provide granular mechanistic insights into
the spatial and temporal patterning of intercellular signaling pathways driven by FOXF1 in human lung
alveologenesis, and provide new therapeutic targets to re-establish normal alveolar-capillary interface in various
lung developmental disorders.
项目摘要
这项研究的首要目标是揭示FOXF 1介导的细胞凋亡的分子机制。
多种肺泡内皮和上皮细胞亚型的时间和空间协调。FOXF 1(叉头
Box F1)是一种转录因子,在肺血管发育、稳态和修复中起关键作用
伤后FOXF 1杂合缺失或点突变与肺泡毛细血管发育不良相关
肺静脉错位(ACD/MPV),一种致命的肺部发育障碍,无法治愈。虽然
已经建立了Foxf 1突变小鼠模型来研究ACD,在基因标记中存在某些变异
EC亚型和肺泡化的发育时间在小鼠与人类中的差异,限制了其在
了解ACD的人类病因因此,FOXF 1如何调控下游基因网络仍不清楚
驱动肺泡内皮细胞(EC)亚型的形成,维持正常的EC-上皮细胞(EpiC)
人类肺泡形成过程中的串扰。我们的初步研究表明FOXF 1突变导致不同的
两种新发现的肺泡EC亚型--aCap和aCap的细胞群和转录组学变化
通用毛细管(gCap),基于对照和ACD人肺组织中的单核RNA测序。更
有趣的是,虽然FOXF 1在上皮细胞系中不表达,但肺泡1型(AT 1)EpiC群体在上皮细胞系中表达,
在FOXF 1中,损伤相关的瞬时上皮祖细胞(DATPs)显著减少,
变异人肺配体-受体结合分析显示aCap(TGFB 2)-AT 1中TGFβ信号传导被破坏
(TGFBR 2/3)相互作用。因此,我们假设FOXF 1在aCap和gCap中调节不同的途径,
细胞,并且aCap的FOXF 1依赖性TGFβ2分泌在维持AT 1身份和功能中至关重要。我们
我建议用以下具体目标来检验这一假设:目标1:确定FOXF 1在调节
肺泡EC亚型的分化和功能。目的2:确定aCap细胞对维持
AT 1身份和功能。目的3:使用iPSC衍生的类器官揭示FOXF 1介导的早期肺发育
系统.目的3:建立对照组和ACD诱导组的血管化肺泡类器官模型
多能干细胞(iPSC),研究FOXF 1基因调控和动态EC-EpiC相互作用,
多个肺发育阶段。这三个目标的完成将为以下方面提供精细的机制见解:
FOXF 1在人肺中驱动的细胞间信号传导途径的时空模式
肺泡发生,并提供新的治疗目标,以重建正常的肺泡毛细血管界面,在各种
肺发育障碍
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mingxia Gu其他文献
Mingxia Gu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mingxia Gu', 18)}}的其他基金
Uncovering compensatory mechanisms in family members with disease causing mutations of pulmonary hypertension
揭示患有导致肺动脉高压突变的疾病的家庭成员的补偿机制
- 批准号:
10203182 - 财政年份:2020
- 资助金额:
$ 66.04万 - 项目类别:
Uncovering compensatory mechanisms in family members with disease causing mutations of pulmonary hypertension
揭示患有导致肺动脉高压突变的疾病的家庭成员的补偿机制
- 批准号:
10460463 - 财政年份:2020
- 资助金额:
$ 66.04万 - 项目类别:
Uncovering compensatory mechanisms in family members with disease causing mutations of pulmonary hypertension
揭示患有导致肺动脉高压突变的疾病的家庭成员的补偿机制
- 批准号:
10238179 - 财政年份:2020
- 资助金额:
$ 66.04万 - 项目类别:
Uncovering compensatory mechanisms in family members with disease causing mutations of pulmonary hypertension
揭示患有导致肺动脉高压突变的疾病的家庭成员的补偿机制
- 批准号:
9222066 - 财政年份:2017
- 资助金额:
$ 66.04万 - 项目类别:
相似国自然基金
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
- 批准号:62302218
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
- 批准号:82001520
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
- 批准号:81802809
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
- 批准号:31802046
- 批准年份:2018
- 资助金额:27.0 万元
- 项目类别:青年科学基金项目
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
- 批准号:31801915
- 批准年份:2018
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
- 批准号:31871331
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
相似海外基金
Project #2 Integrated single-nucleus multi-omics (ATAC-seq+RNA-seq or chromatin accessibility + RNA-seq) of human TGs
项目
- 批准号:
10806548 - 财政年份:2023
- 资助金额:
$ 66.04万 - 项目类别:
A transposase system for integrative ChIP-exo and ATAC-seq analysis at single-cell resolution
用于单细胞分辨率综合 ChIP-exo 和 ATAC-seq 分析的转座酶系统
- 批准号:
10210424 - 财政年份:2018
- 资助金额:
$ 66.04万 - 项目类别:
EAPSI: Developing Single Nucleus ATAC-seq to Map the Ageing Epigenome
EAPSI:开发单核 ATAC-seq 来绘制衰老表观基因组图谱
- 批准号:
1714070 - 财政年份:2017
- 资助金额:
$ 66.04万 - 项目类别:
Fellowship Award
A cloud-based learning module to analyze ATAC-seq and single cell ATAC-seq data
基于云的学习模块,用于分析 ATAC-seq 和单细胞 ATAC-seq 数据
- 批准号:
10558379 - 财政年份:2001
- 资助金额:
$ 66.04万 - 项目类别: